STEQEYMA
These highlights do not include all the information needed to use STEQEYMA safely and effectively. See full prescribing information for STEQEYMA. STEQEYMA (ustekinumab-stba) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 STEQEYMA (ustekinumab-stba) is biosimilar to STELARA (ustekinumab)
66085e17-e3f2-4196-8c81-87448e804b0c
HUMAN PRESCRIPTION DRUG LABEL
Apr 21, 2025
CELLTRION USA Inc.
DUNS: 116587378
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ustekinumab-stba
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
ustekinumab-stba
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
ustekinumab-stba
Product Details
FDA regulatory identification and product classification information